Company profile
QuantuMDx - Multiplex PCR solutions for the Point of Need
% is a progressive medical technology company passionate about creating rapid multiplex PCR solutions for the Point of Need.
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUxNTAyNDI5N2FkaXF6a2N4
Published 08 Apr 2026 15:22
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ0NTEyNjQyMmFkaXF6a2N4
Published 27 Nov 2024 12:22
AAMD | Transaction MzQ0NDQwNDIzMGFkaXF6a2N4 | Paper/PDF filed
Published 23 Nov 2024 10:47
AA | Transaction MzQzODkxMzc2OGFkaXF6a2N4
Published 09 Oct 2024 11:09
Company registered at Companies House
1 Oct 2019 to 28 Feb 2021
Awaiting Public Project Summary
1 Apr 2018 to 31 Mar 2020
To develop scalable smart material coatings for large scale production of microfluidic medical devices.
1 Oct 2013 to 31 Mar 2016
The Q-TB project addresses some fundermental issues in the fight against tuberculosis. Firstly (SPEED & QUALITY) the project will deliver a technology that will enable patients to receive referral standard molecular diagnostic results within minutes, as they wait with their treating physician. Secondly (PORTABLE), if the patient is in a rural loctation, s...
1 Jul 2013 to 30 Jun 2016
This project is concerned with the development of a fully integrated, low test cost, sample to result medical device that will enable a histopathologist (or a technician) to perform multiplex genotyping and tumour staging & profiling, within minutes, from formalin fixed &/or fresh tissue samples, providing a molecular adjunct to a histopathologist's stand...
